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Introduction 
 
Atherosclerosis and consequently cardiovascular 
disease is one of the leading causes of morbidity and 
mortality in western societies. Over the last decades 
the outcome of myocardial ischemia dramatically 
improved in Hungary. However, patients with 
peripheral artery disease (PAD) are still at high risk 
of severe morbidity and mortality. Therefore, 
investigations about PAD, such as this one, are very 
important in order to minimise complications and 
reduce mortality.  
 
Aims 
 
The connection between extravascular and 
intravascular calcification in patients with PAD was 
evaluated.  The prevalence of osteoporosis and the 
possible mechanisms resulting in a connection 
between the 2 diseases were determined. Markers of 
calcification such as complement components or 
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Fetuin-a were compared to the clinical signs of 
lower limb ischemia. Furthermore, baseline level of 
these calcifying parameters were compared to 
cardiovascular outcome. These findings could help 
to prevent and treat osteoporosis in patients with 
PAD and to identify future cardiovascular risk in 
these patients.  
 
Methods 
 
In cross sectional and follow up studies patients with 
lower limb atherosclerosis and peripheral artery 
disease were recruited at the Heart and Vascular 
Department of Semmelweis University. Laboratory 
investigations (complement component3 and 4 (C3, 
C4), bone turnover markers, fetuin-A), angiography 
based Bollinger score (BS), clinical parameters such 
as ankle brachial Doppler index (ABI) and Fontaine 
stadiums and the site of the atherosclerotic lesion 
were evaluated too. To assess the extent of 
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generalised calcification an ultrasound based score 
was used. Bone mineral density (BMD) was 
measured with DEXA scan on 3 anatomical sites 
such at the lumbar fourth and fifth vertebras, the 
femoral and radial head. Our patients were followed 
up and monitored for any new cardiovascular event 
such as new onset of myocardial infarction (MI), 
embolic stroke or further vascular intervention. 
 
Results  
 
Previously to the enrolment in to the study 9% of our 
patients were diagnosed with osteoporosis. 
Following the DEXA scan we identified further 31% 
of patients suffering from osteoporosis and 37% of 
abnormally decreased bone mass (Figure 1.).  
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Figure 1. The prevalence of osteoporosis before and 
after DEXA scan 
 
Osteoporosis was diagnosed in 59% of our female 
and 18% of our male subjects, which is higher than 
in similar aged non atherosclerotic population 
(female: 40%, male: 20%). Furthermore 45% of our 
male patients suffered with decreased bone mass 
(Figure 2.). 
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Figure 2. The prevalence of osteoporosis and 
osteopenia in male and female subjects. 
 
A connection was found between the blood flow to 
a particular bony area where bone mineral density 
was measured (lumbar spine BMD and BS p=0.038, 
r=-0.467, femoral BMD and BS p=0.002, r=-0.642). 
In case of intact blood flow to the bone these 
associations were not seen (lumbar BMD and BS 
p=0.514,r=0.118, femoral BMD and BS p=0.505, 
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r=0.120). Other previously described mechanisms 
did not affect the connection between the 2 diseases 
in our cohort. The level of bone turnover markers 
was not associated to atherosclerosis.The median 
follow up time was 2.7 years. High baseline level of 
C3 was associated to future myocardial infarction in 
patients with peripheral artery disease (HR=1.56, 
p=0.0001). A high and low risk patient group were 
created based on ROC analysis of C3. There was a 
significant difference in the survival of these groups 
(p=0.0001) (Figure 3.). 
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 Figure 3. Kaplan Meier analysis. Survival of high and low risk patient groups. 
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Table 1. Regression analysis. The connection 
between C3 and MI is independent of CRP, 
homocisteine and  creatinine 
 
Furthermore, the connection between C3 and new 
myocardial infarction was independent of CRP, 
homocysteine and creatinine (Table 1.). The level of 
the complement components was associated to the 
clinical parameters of lower limb ischemia (ABI and 
C3 p=0.014, r=-0.246, ABI and C4 p=0.011, r=-
0.259, BS and C3 p=0.028, r=-0.357) (Figure 4-5).  
  Új AMI 
(n=24) 
   
 HR 95% CI χ2 p 
Model 1         
Kreatinin (umol/l) 1.17 0.82-1.66 0.81 0.36 
Homocisztein 
(umol/l) 1.41 0.98-2.04 3.56 0.05 
CRP (mg/l) 1.25 0.99-1.57 3.65 0.05 
C3 (g/l) 1.59 1.11-2.27 6.54 0.01 
Model 2         
Kreatinin (umol/l) 1.14 0.77-1.69 0.47 0.49 
Homocisztein 
(umol/l) 1.39 0.95-2.01 2.99 0.08 
CRP (mg/l) 1.26 0.99-1.60 3.79 0.05 
C3 > 1.55 g/l 3.96 1.69-9.28 10.06 0.002 
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Figure 4. C3 and C4 is associated to ankle-brachial 
pressure index 
 
Figure 5. C3 is associated to Bollinger score 
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Conclusion 
 
There is a connection between the extent of 
atherosclerosis and osteoporosis in patients with 
PAD. This is a result of the reduced blood flow to 
the bone due to atherosclerosis. The higher 
prevalence of osteoporosis in patients with PAD 
indicates regular DEXA scan and BMD 
measurement. Supportive therapy to preserve bone 
mass is also important. Complement 3 is an 
independent risk factor of future myocardial 
ischemia in lower limb atherosclerosis and it is 
associated to the clinical parameters of the disease. 
Therefore, it is important to consider more frequent 
complement measurements to identify high risk 
patients. 
 
 
 
 
 12 
List of Author`s Publications 
 
Fehérvári M , Krepuska M , Széplaki G , Apor A , 
Sótonyi P , Prohászka Z , Acsády G , Szeberin Z 
The level of complement C3 is associated with the 
severity of atherosclerosis but not with arterial 
calcification in peripheral artery disease. 
INTERNATIONAL ANGIOLOGY 33:(1) pp. 35-
41. (2014), IF:0.833 
 
Fehérvári M , Sarkadi H , Krepuska M , Sótonyi P , 
Acsády G , Entz L , Lakatos P , Szeberin Z 
Bone Mineral Density is Associated with Site-
Specific Atherosclerosis in Patients with Severe 
Peripheral Artery Disease 
CALCIFIED TISSUE INTERNATIONAL 93:(1) 
pp. 55-61. (2013), IF:2.748 
 
 
 
 13 
Fehérvári M, Krepuska M , Csobay-Novák Cs , 
Lakatos P, Oláh Z , Acsády G, Szeberin Z 
A csontritkulás előfordulásának vizsgálata 
perifériás verőérbetegekben [Prevalence of 
osteoporosis in patients with severe peripheral 
artery disease] 
ORVOSI HETILAP 154:(10) pp. 369-375. (2013) 
 
Szeberin Z , Fehérvári M , Krepuska M, Apor A , 
Rimely E , Sarkadi H , Bíró G , Sótonyi P , 
Széplaki G , Szabolcs Z , Prohászka Z , Kalabay L , 
Acsády G 
Fetuin-A serum levels in patients with aortic 
aneurysms of Marfan syndrome and atherosclerosis 
EUROPEAN JOURNAL OF CLINICAL 
INVESTIGATION 41:(2) pp. 176-182. (2011),  
IF: 3.018 
 
 
 
 14 
Szeberin Z , Fehervári M , Krepuska M , Apor A , 
Rimely E , Sarkadi H , Széplaki G , Prohászka Z , 
Kalabay L , Acsády G 
Serum fetuin-A levels inversely correlate with the 
severity of arterial calcification in patients with 
chronic lower extremity atherosclerosis without 
renal disease. 
INTERNATIONAL ANGIOLOGY 30:(5) pp. 474-
480. (2011), IF:1.652 
 
II. Other publications 
 
Krepuska M , Szeberin Z , Sótonyi P , Sarkadi H, 
Fehervári M , Apor A , Rimely E , Prohászka Z , 
Acsády G 
Serum level of soluble Hsp70 is associated with 
vascular calcification 
CELL STRESS & CHAPERONES 16:(3) pp. 257-
265. (2011), IF:3.013 
 
 15 
Szeberin Z , Dósa E , Fehérvári M , Csobay-Novák 
C , Pintér N , Entz L 
Early- and long-term outcome after open surgical 
suprarenal aortic fenestration in patients with 
complicated acute type B aortic dissection 
EUROPEAN JOURNAL OF VASCULAR AND 
ENDOVASCULAR SURGERY 50:(1) pp. 44-50. 
(2015), IF: 2.976  
 
Kovács H , Fehérvári M , Forgó B , Gősi G , Oláh 
Z , Csobay-Novák Cs , Entz L , Szeberin Z 
Electiv infrarenalis aortaaneurysma sebészi 
kezelésének korai és késői mortalitása és 
morbiditása [Early and late mortality and morbidity 
of elective infrarenal aortic aneurysm repair] 
MAGYAR SEBÉSZET 67:(5) pp. 297-303. (2014) 
IF:0 
 
 
 
 16 
Biró G , Szabó G , Fehervári M , Münch Z , 
Szeberin Z , Acsády G 
Late outcome following open surgical management 
of secondary aortoenteric fistula. 
LANGENBECKS ARCHIVES OF SURGERY 
396:(8) pp. 1221-1229. (2011) IF:1.807 
 
Szeberin Z , Münch Z , Fehérvári M , Bíró G , Entz 
L , Acsády G 
Ezüst-acetáttal bevont Dacron grafttal végzett 
rekonstrukciós érmutétek középtávú eredményei 
MAGYAR SEBÉSZET 63:(6) pp. 369-373. (2010) 
IF:0 
 
